Please enable JavaScript to continue using this application.

Compare $RNXT vs $XBIT | Chartloom

Compare

$RNXT vs $XBIT

RenovoRx Inc · XBiotech Inc

RNXT

RenovoRx Inc

XBIT

XBiotech Inc

Compare $RNXT vs $XBIT

Comparing RenovoRx Inc and XBiotech Inc

RNXTRenovoRx Inc

XBITXBiotech Inc

RNXTRenovoRx Inc

Market cap

$58M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.70x

Rev growth (TTM)

198.5%

YTD performance

53.3%

52W performance

5.8%

FCF yield

-20.7%

XBITXBiotech Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-14.9%

FCF yield

-58.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RNXT

XBIT

Detailed metrics comparison

RNXT

RenovoRx Inc

XBIT

XBiotech Inc

Market Cap

RNXT$58M

XBIT$70M

Enterprise Value

RNXT$48M

XBIT$-40M

Price

RNXT$1.28

XBIT$2.29

P/E Ratio

RNXTN/A

XBITN/A

P/S Ratio

RNXT29.18x

XBIT16.50x

EV/Sales

RNXT24.39x

XBIT-10.81x

EV/EBITDA

RNXT0.00x

XBIT-0.06x

P/B Ratio

RNXT7.94x

XBIT0.52x

P/FCF Ratio

RNXTN/A

XBITN/A

EV/FCF

RNXT-4.04x

XBIT0.97x

PEG Ratio

RNXTN/A

XBITN/A

Forward P/E (NTM)

RNXTN/A

XBITN/A

Forward P/S (NTM)

RNXT8.70x

XBITN/A

Revenue (TTM)

RNXT$2M

XBIT$0

Revenue Growth (YoY)

RNXT198.5%

XBITN/A

Forward Rev Growth

RNXT195.2%

XBIT0.0%

Gross Margin (TTM)

RNXT84.4%

XBIT83.8%

Operating Margin (TTM)

RNXT0.0%

XBIT0.0%

EBITDA Margin (TTM)

RNXT-684.9%

XBIT0.0%

Net Margin (TTM)

RNXT-621.7%

XBIT0.0%

FCF Margin (TTM)

RNXT-604.1%

XBITN/A

Net Income (TTM)

RNXT$-12M

XBIT$-45M

FCF (TTM)

RNXT$-12M

XBIT$-41M

EPS (TTM)

RNXT-$0.26

XBIT-$1.48

ROE (TTM)

RNXT-14563.0%

XBIT-3162.0%

ROA (TTM)

RNXT-10984.0%

XBIT-3029.0%

ROIC (TTM)

RNXT-14563.0%

XBIT-3162.0%

Cash

RNXT$9M

XBIT$110M

Debt

RNXT$0

XBIT$0

Net Cash/Debt

RNXT$9M

XBIT$110M

Current Ratio (TTM)

RNXT5.74x

XBIT33.15x

Quick Ratio (TTM)

RNXT5.37x

XBIT32.75x

Debt/Equity (TTM)

RNXT0.00x

XBIT0.00x

Debt/Assets (TTM)

RNXT0.0%

XBIT0.0%

Interest Coverage (TTM)

RNXTN/A

XBITN/A

Net Debt/EBITDA (TTM)

RNXT0.00x

XBIT0.00x

Beta

RNXT1.07

XBIT0.73

52W Performance

RNXT5.8%

XBIT-14.9%

YTD Performance

RNXT53.3%

XBIT-3.8%

% from 52W High

RNXT-50.6%

XBIT-33.4%

% from 52W Low

RNXT82.7%

XBIT9.6%

Asset Turnover (TTM)

RNXT0.18x

XBIT0.02x

FCF Yield (TTM)

RNXT-20.7%

XBIT-58.5%

Earnings Yield (TTM)

RNXT-21.3%

XBIT-64.6%

Dividend Yield (TTM)

RNXTN/A

XBITN/A

Rule of 40

RNXT-405.6

XBIT0.0

EV/GP/RG

RNXT0.12

XBITN/A

Ticker research

View RNXT research View XBIT research

Metric	RNXT RenovoRx Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$58M	$70M
Enterprise Value	$48M	$-40M
Price	$1.28	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	29.18x	16.50x
EV/Sales	24.39x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	7.94x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.04x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.70x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	198.5%	N/A
Forward Rev Growth	195.2%	0.0%
Profitability
Gross Margin (TTM)	84.4%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-684.9%	0.0%
Net Margin (TTM)	-621.7%	0.0%
FCF Margin (TTM)	-604.1%	N/A
Net Income (TTM)	$-12M	$-45M
FCF (TTM)	$-12M	$-41M
EPS (TTM)	-$0.26	-$1.48
ROE (TTM)	-14563.0%	-3162.0%
ROA (TTM)	-10984.0%	-3029.0%
ROIC (TTM)	-14563.0%	-3162.0%
Financial Health
Cash	$9M	$110M
Debt	$0	$0
Net Cash/Debt	$9M	$110M
Current Ratio (TTM)	5.74x	33.15x
Quick Ratio (TTM)	5.37x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	0.73
52W Performance	5.8%	-14.9%
YTD Performance	53.3%	-3.8%
% from 52W High	-50.6%	-33.4%
% from 52W Low	82.7%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.02x
FCF Yield (TTM)	-20.7%	-58.5%
Earnings Yield (TTM)	-21.3%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-405.6	0.0
EV/GP/RG	0.12	N/A
Ticker research	View RNXT research	View XBIT research

Valuation

P/S Ratio

XBIT

16.50x

RNXT

29.18x

EV/FCF

RNXT

-4.04x

XBIT

0.97x

Growth & revenue

Revenue Growth TTM

RNXT

198.5%

Forward Revenue Growth

RNXT

195.2%

XBIT

0.0%

Profitability & performance

Gross Margin

RNXT

84.4%

XBIT

83.8%

ROE

XBIT

-3162.0%

RNXT

-14563.0%

FCF Yield %

RNXT

-20.7%

XBIT

-58.5%

52-Week Performance

RNXT

5.8%

XBIT

-14.9%

Detailed metrics comparison

RNXT

RenovoRx Inc

XBIT

XBiotech Inc

Market Cap

RNXT$58M

XBIT$70M

Enterprise Value

RNXT$48M

XBIT$-40M

Price

RNXT$1.28

XBIT$2.29

P/E Ratio

RNXTN/A

XBITN/A

P/S Ratio

RNXT29.18x

XBIT16.50x

EV/Sales

RNXT24.39x

XBIT-10.81x

EV/EBITDA

RNXT0.00x

XBIT-0.06x

P/B Ratio

RNXT7.94x

XBIT0.52x

P/FCF Ratio

RNXTN/A

XBITN/A

EV/FCF

RNXT-4.04x

XBIT0.97x

PEG Ratio

RNXTN/A

XBITN/A

Forward P/E (NTM)

RNXTN/A

XBITN/A

Forward P/S (NTM)

RNXT8.70x

XBITN/A

Revenue (TTM)

RNXT$2M

XBIT$0

Revenue Growth (YoY)

RNXT198.5%

XBITN/A

Forward Rev Growth

RNXT195.2%

XBIT0.0%

Gross Margin (TTM)

RNXT84.4%

XBIT83.8%

Operating Margin (TTM)

RNXT0.0%

XBIT0.0%

EBITDA Margin (TTM)

RNXT-684.9%

XBIT0.0%

Net Margin (TTM)

RNXT-621.7%

XBIT0.0%

FCF Margin (TTM)

RNXT-604.1%

XBITN/A

Net Income (TTM)

RNXT$-12M

XBIT$-45M

FCF (TTM)

RNXT$-12M

XBIT$-41M

EPS (TTM)

RNXT-$0.26

XBIT-$1.48

ROE (TTM)

RNXT-14563.0%

XBIT-3162.0%

ROA (TTM)

RNXT-10984.0%

XBIT-3029.0%

ROIC (TTM)

RNXT-14563.0%

XBIT-3162.0%

Cash

RNXT$9M

XBIT$110M

Debt

RNXT$0

XBIT$0

Net Cash/Debt

RNXT$9M

XBIT$110M

Current Ratio (TTM)

RNXT5.74x

XBIT33.15x

Quick Ratio (TTM)

RNXT5.37x

XBIT32.75x

Debt/Equity (TTM)

RNXT0.00x

XBIT0.00x

Debt/Assets (TTM)

RNXT0.0%

XBIT0.0%

Interest Coverage (TTM)

RNXTN/A

XBITN/A

Net Debt/EBITDA (TTM)

RNXT0.00x

XBIT0.00x

Beta

RNXT1.07

XBIT0.73

52W Performance

RNXT5.8%

XBIT-14.9%

YTD Performance

RNXT53.3%

XBIT-3.8%

% from 52W High

RNXT-50.6%

XBIT-33.4%

% from 52W Low

RNXT82.7%

XBIT9.6%

Asset Turnover (TTM)

RNXT0.18x

XBIT0.02x

FCF Yield (TTM)

RNXT-20.7%

XBIT-58.5%

Earnings Yield (TTM)

RNXT-21.3%

XBIT-64.6%

Dividend Yield (TTM)

RNXTN/A

XBITN/A

Rule of 40

RNXT-405.6

XBIT0.0

EV/GP/RG

RNXT0.12

XBITN/A

Ticker research

View RNXT research View XBIT research

Metric	RNXT RenovoRx Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$58M	$70M
Enterprise Value	$48M	$-40M
Price	$1.28	$2.29
P/E Ratio	N/A	N/A
P/S Ratio	29.18x	16.50x
EV/Sales	24.39x	-10.81x
EV/EBITDA	0.00x	-0.06x
P/B Ratio	7.94x	0.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.04x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.70x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	198.5%	N/A
Forward Rev Growth	195.2%	0.0%
Profitability
Gross Margin (TTM)	84.4%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-684.9%	0.0%
Net Margin (TTM)	-621.7%	0.0%
FCF Margin (TTM)	-604.1%	N/A
Net Income (TTM)	$-12M	$-45M
FCF (TTM)	$-12M	$-41M
EPS (TTM)	-$0.26	-$1.48
ROE (TTM)	-14563.0%	-3162.0%
ROA (TTM)	-10984.0%	-3029.0%
ROIC (TTM)	-14563.0%	-3162.0%
Financial Health
Cash	$9M	$110M
Debt	$0	$0
Net Cash/Debt	$9M	$110M
Current Ratio (TTM)	5.74x	33.15x
Quick Ratio (TTM)	5.37x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	0.73
52W Performance	5.8%	-14.9%
YTD Performance	53.3%	-3.8%
% from 52W High	-50.6%	-33.4%
% from 52W Low	82.7%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.02x
FCF Yield (TTM)	-20.7%	-58.5%
Earnings Yield (TTM)	-21.3%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-405.6	0.0
EV/GP/RG	0.12	N/A
Ticker research	View RNXT research	View XBIT research